Akebia Therapeutics Inc (STU:AX9)
€ 0.98 +0.077 (+8.59%) Market Cap: 269.17 Mil Enterprise Value: 170.92 Mil PE Ratio: 0 PB Ratio: 11.18 GF Score: 51/100

Akebia Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 17, 2026 / 02:00PM GMT
Release Date Price: €0.8834 (+5.12%)
Adrian Adams
Akebia Therapeutics Inc - Independent Chairman of the Board

Good morning, ladies and gentlemen. I want to welcome all of you to the 2026 Annual Meeting of Stockholders of Akebia Therapeutics. I'm Adrian Adams, Chairperson of the Board of Directors of Akebia Therapeutics, and I will be presiding at this meeting. At this time, I call the meeting to order.

We are holding this meeting in an all-virtual format and are pleased to have everyone join this live webcast. We have designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in-person meeting.

I'd now like to take this opportunity to welcome the other members of Akebia's Board of Directors and the company's executive leadership team who are present here today. The other directors present today are Ronald Frieson, Michael Rogers, Cynthia Smith, Myles Wolf, Philip Vickers, and LeAnne Zumwalt. John Butler, who is a director and Akebia's President and Chief Executive Officer, is also present.

Also present today are the following other members of Akebia's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot